Literature DB >> 8737687

Tricuspid valve reconstruction, a treatment option in acute endocarditis.

R Lange1, R De Simone, R Bauernschmitt, A Tanzeem, C Schmidt, S Hagl.   

Abstract

Tricuspid valve endocardititis is treated surgically by total valve excision or valve replacement. Both procedures are controversial with regard to the hemodynamic consequences and to the long-term prognosis. In the following, results of tricuspid valve repair in acute infective endocarditis are reported and discussed as an additional treatment option. Between January 1988 and December 1993, 118 patients were operated on for acute valve endocarditis at our institution. Eleven of these patients had tricuspid valve endocarditis, isolated (n = 7) or combined with endocarditis of a left-sided valve (n = 4). In the cases with isolated tricuspid valve endocarditis, the indication for surgery was intractable infection in six and hemodynamically relevant tricuspid insufficiency in one out of seven patients. In all patients with associated left-sided endocarditis, the indication was hemodynamic deterioration. In eight patients the tricuspid valve endocarditis was treated as follows: debridement, vegectomy, patch reconstruction of the cusps, reducing the cusps to two. In three patients reconstruction was not possible because of extensive involvement of all parts of the valve, including the valve ring and the papillary muscles. In these patients primary valve replacement (n = 1) or valve excision with secondary replacement (n = 2) was performed. In four patients tricuspid reconstruction was combined with mitral (n = 1), aortic (n = 1) or double valve replacement (n = 2). Postoperatively, signs of infection vanished in all surviving patients (n = 10) and tricuspid valve endocarditis healed without recurrences. Implanted prosthetic material did not lead to recurrent infection. One patient died early postoperatively after valve excision, in septic shock and multi-organ failure. In seven patients late echocardiographic follow-up showed tricuspid regurgitation grade 0 in three patients, I in two, II in one and III in one. Our results suggest that valve repair is a reasonable treatment option for tricuspid valve endocarditis in all cases with localized infection of the valve. Only if extensive valve destruction excludes valve repair, would we now favor primary valve replacement over simple valvulectomy. In all other cases primary valve reconstruction is the treatment of choice for tricuspid valve endocarditis, if surgery is indicated.

Entities:  

Mesh:

Year:  1996        PMID: 8737687     DOI: 10.1016/s1010-7940(96)80089-3

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  8 in total

1.  Native tricuspid valve endocarditis in a young woman.

Authors:  V A Papapanagiotou; M G Foukarakis; J N Fotiadis; E P Matsakas; A A Zacharoulis
Journal:  Postgrad Med J       Date:  1998-10       Impact factor: 2.401

Review 2.  Tricuspid regurgitation: pathophysiology and management.

Authors:  Rashmi Thapa; Buddhadeb Dawn; Jayant Nath
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

3.  Infective endocarditis with congenital heart disease.

Authors:  Yasuyuki Suzuki; Kazuyuki Daitoku; Masahito Minakawa; Kozo Fukui; Ikuo Fukuda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-07

4.  Tricuspid-valve repair for pacemaker leads endocarditis.

Authors:  Federica Iezzi; Roberto Cini; Paolo Sordini
Journal:  BMJ Case Rep       Date:  2010-12-20

5.  Repair for active infective atrioventricular valve endocarditis: 23-year single center experience.

Authors:  Michele Musci; Michael Hübler; Aref Amiri; Julia Stein; Susanne Kosky; Yuguo Weng; Miralem Pasic; Roland Hetzer
Journal:  Clin Res Cardiol       Date:  2011-06-25       Impact factor: 5.460

6.  Cusp commissuroplasty for tricuspid valve endocarditis.

Authors:  Yoshiharu Hamanaka; Norimasa Mitsui; Shinji Hirai; Mitsuhiro Isaka; Taira Kobayashi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-11

7.  Infective Endocarditis in Intravenous Drug Abusers.

Authors:  José M. Miró; Asuncion Moreno; Carlos A. Mestres
Journal:  Curr Infect Dis Rep       Date:  2003-08       Impact factor: 3.725

8.  Tricuspid anterior leaflet replacement with autologous pericardium and polytetrafluoroethylene chordae, followed by edge-to-edge repair.

Authors:  Raúl García-Rinaldi
Journal:  Tex Heart Inst J       Date:  2007
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.